Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)
China
· Delayed Price · Currency is CNY 16.59
-0.06 (-0.36%)
Jun 16, 2025, 2:45 PM CST
SHA:688553 Revenue
Sichuan Huiyu Pharmaceutical had revenue of 239.05M CNY in the quarter ending March 31, 2025, a decrease of -1.46%. This brings the company's revenue in the last twelve months to 1.09B, up 17.05% year-over-year. In the year 2024, Sichuan Huiyu Pharmaceutical had annual revenue of 1.09B with 18.05% growth.
Revenue (ttm)
1.09B
Revenue Growth
+17.05%
P/S Ratio
6.47
Revenue / Employee
789.31K
Employees
1,382
Market Cap
7.06B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |